These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
818 related items for PubMed ID: 22634175
1. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Chang ST, Tenforde AS, Grimsrud CD, O'Ryan FS, Gonzalez JR, Baer DM, Chandra M, Lo JC. Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175 [Abstract] [Full Text] [Related]
2. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. Puhaindran ME, Farooki A, Steensma MR, Hameed M, Healey JH, Boland PJ. J Bone Joint Surg Am; 2011 Jul 06; 93(13):1235-42. PubMed ID: 21776577 [Abstract] [Full Text] [Related]
10. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. Hagen JE, Miller AN, Ott SM, Gardner M, Morshed S, Jeray K, Alton TB, Ren D, Abblitt WP, Krieg JC. J Bone Joint Surg Am; 2014 Nov 19; 96(22):1905-9. PubMed ID: 25410509 [Abstract] [Full Text] [Related]
17. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use. Weil YA, Rivkin G, Safran O, Liebergall M, Foldes AJ. J Trauma; 2011 Jul 19; 71(1):186-90. PubMed ID: 21610533 [Abstract] [Full Text] [Related]
19. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center. Koh JH, Myong JP, Yoo J, Lim YW, Lee J, Kwok SK, Park SH, Ju JH. Osteoporos Int; 2017 Nov 19; 28(11):3251-3259. PubMed ID: 28748389 [Abstract] [Full Text] [Related]